Literature DB >> 12535055

A review of current knowledge on Electronic Vision Enhancement Systems for the visually impaired.

James S Wolffsohn1, Rachael C Peterson.   

Abstract

Magnification can be provided to assist those with visual impairment to make the best use of remaining vision. Electronic transverse magnification of an object was first conceived for use in low vision in the late 1950s, but has developed slowly and is not extensively prescribed because of its relatively high cost and lack of portability. Electronic devices providing transverse magnification have been termed closed-circuit television (CCTVs) because of the direct cable link between the camera imaging system and monitor viewing system, but this description generally refers to surveillance devices and does not indicate the provision of features such as magnification and contrast enhancement. Therefore, the term Electronic Vision Enhancement Systems (EVES) is proposed to better distinguish and describe such devices. This paper reviews current knowledge on EVES for the visually impaired in terms of: classification; hardware and software (development of technology, magnification and field-of-view, contrast and image enhancement); user aspects (users and usage, reading speed and duration, and training); and potential future development of EVES.

Entities:  

Mesh:

Year:  2003        PMID: 12535055     DOI: 10.1046/j.1475-1313.2003.00087.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  11 in total

Review 1.  High Tech Aids Low Vision: A Review of Image Processing for the Visually Impaired.

Authors:  Howard Moshtael; Tariq Aslam; Ian Underwood; Baljean Dhillon
Journal:  Transl Vis Sci Technol       Date:  2015-08-14       Impact factor: 3.283

Review 2.  [Electronic vision aids : New options for rehabilitation of the visually impaired].

Authors:  N Celik; K Rohrschneider
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

3.  Low Vision Enhancement with Head-mounted Video Display Systems: Are We There Yet?

Authors:  Ashley D Deemer; Christopher K Bradley; Nicole C Ross; Danielle M Natale; Rath Itthipanichpong; Frank S Werblin; Robert W Massof
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

4.  Effects of standard training in the use of closed-circuit televisions in visually impaired adults: design of a training protocol and a randomized controlled trial.

Authors:  Marloes C Burggraaff; Ruth M A van Nispen; Bart J M Melis-Dankers; Ger H M B van Rens
Journal:  BMC Health Serv Res       Date:  2010-03-10       Impact factor: 2.655

5.  Causes of low vision and their management at Korle Bu Teaching Hospital, Accra, GHANA.

Authors:  E M Ackuaku-Dogbe; B Abaidoo; Z I Braimah; G Afenyo; S Asiedu
Journal:  J West Afr Coll Surg       Date:  2016 Jul-Sep

6.  Evaluation of the iPad as a low vision aid for improving reading ability.

Authors:  Shamim A Haji; Kumar Sambhav; Sandeep Grover; Kakarla V Chalam
Journal:  Clin Ophthalmol       Date:  2014-12-19

7.  Evaluation of a gaze-controlled vision enhancement system for reading in visually impaired people.

Authors:  Carlos Aguilar; Eric Castet
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

8.  Clinical characteristics and causes of visual impairment in a low vision clinic in northern Jordan.

Authors:  May M Bakkar; Eman A Alzghoul; Mera F Haddad
Journal:  Clin Ophthalmol       Date:  2018-04-03

9.  The Effect of a Head-mounted Low Vision Device on Visual Function.

Authors:  Walter Wittich; Marie-Céline Lorenzini; Samuel N Markowitz; Michael Tolentino; Scott A Gartner; Judith E Goldstein; Gislin Dagnelie
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

10.  Tuneable Liquid Crystal Micro-Lens Array for Image Contrast Enhancement in a Pixelated Thin Film Photo-Transistor Flat Panel Imager.

Authors:  Kun Li; Daping Chu; Jiaqi Chu; Shuhei Kitajima; Tokiyoshi Matsuda; Mutsu Kimura
Journal:  Micromachines (Basel)       Date:  2017-06-26       Impact factor: 2.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.